Penicillin to Prevent Early Rheumatic Heart Disease in School-Aged Children

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 9622 participants.

Also called NCT07798232

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 9,622 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07798232
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Uganda (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07798232. Randomized; single masking; primary purpose prevention. Start 2027-02-01 (anticipated); primary completion 2031-07-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Penicillin to Prevent Early Rheumatic Heart Disease in School-Aged Children
Acronym
MEERCATS 2
Condition
Rheumatic Heart Disease in Children
Intervention (Drug)
Oral Penicillin V
Lead sponsor
Children's Hospital Medical Center, Cincinnati (class: other)
Collaborator
The University of Western Australia (class: other)
Collaborator
Uganda Heart Institute (class: other)
Collaborator
Ochsner Health System (class: other)
Collaborator
Murdoch Childrens Research Institute (class: other)

Record details

Record id
cardio:ct-nct07798232
Content hash
1589be89ae9d8c0496a7fc7fa0f83a42817085f96c5fa236d4d6a62b80c73971